EMBC * Stock Overview
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
+ 2 more risks
Embecta Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$497.96 |
| 52 Week High | US$666.36 |
| 52 Week Low | US$497.96 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -9.13% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -23.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| EMBC * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -9.1% | 0% | 0% |
Return vs Industry: EMBC * underperformed the MX Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: EMBC * underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| EMBC * volatility | |
|---|---|
| EMBC * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: EMBC * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EMBC *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 1,900 | Dev Kurdikar | www.embecta.com |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. Fundamentals Summary
| EMBC * fundamental statistics | |
|---|---|
| Market cap | Mex$20.30b |
| Earnings (TTM) | Mex$802.88m |
| Revenue (TTM) | Mex$18.94b |
25.3x
P/E Ratio1.1x
P/S RatioIs EMBC * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMBC * income statement (TTM) | |
|---|---|
| Revenue | US$1.11b |
| Cost of Revenue | US$368.50m |
| Gross Profit | US$745.00m |
| Other Expenses | US$697.80m |
| Earnings | US$47.20m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 66.91% |
| Net Profit Margin | 4.24% |
| Debt/Equity Ratio | -198.2% |
How did EMBC * perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield72%
Payout RatioDoes EMBC * pay a reliable dividends?
See EMBC * dividend history and benchmarks| Embecta dividend dates | |
|---|---|
| Ex Dividend Date | Aug 24 2023 |
| Dividend Pay Date | Sep 13 2023 |
| Days until Ex dividend | 461 days |
| Days until Dividend pay date | 441 days |
Does EMBC * pay a reliable dividends?
See EMBC * dividend history and benchmarks